HCPCS Level II › J
HCPCS Level II codes starting with J
1,255 codes, page 12 of 13. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | Valid |
| J9178 | Injection, epirubicin hcl, 2 mg | Valid |
| J9179 | Injection, eribulin mesylate, 0.1 mg | Valid |
| J9181 | Injection, etoposide, 10 mg through FY2026 | Terminated |
| J9183 | Gemcitabine intravesical system, 225 mg | Valid |
| J9184 | Injection, gemcitabine hydrochloride (avyxa), 200 mg | Valid |
| J9185 | Injection, fludarabine phosphate, 50 mg | Valid |
| J9186 | Injection, etoposide (avyxa), 1 mg | Valid |
| J9187 | Injection, etoposide, 1 mg | Valid |
| J9190 | Injection, fluorouracil, 500 mg through FY2026 | Terminated |
| J9191 | Injection, fluorouracil (avyxa), 10 mg | Valid |
| J9192 | Injection, fluorouracil, 10 mg | Valid |
| J9196 | Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | Valid |
| J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg | Valid |
| J9199 | Injection, gemcitabine hydrochloride (infugem), 200 mg through FY2026 | Terminated |
| J9200 | Injection, floxuridine, 500 mg | Valid |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Valid |
| J9202 | Goserelin acetate implant, per 3.6 mg | Valid |
| J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg | Valid |
| J9204 | Injection, mogamulizumab-kpkc, 1 mg | Valid |
| J9205 | Injection, irinotecan liposome, 1 mg | Valid |
| J9206 | Injection, irinotecan, 20 mg | Valid |
| J9207 | Injection, ixabepilone, 1 mg | Valid |
| J9208 | Injection, ifosfamide, 1 gram | Valid |
| J9209 | Injection, mesna, 200 mg | Valid |
| J9210 | Injection, emapalumab-lzsg, 1 mg | Valid |
| J9211 | Injection, idarubicin hydrochloride, 5 mg | Valid |
| J9212 | Injection, interferon alfacon-1, recombinant, 1 microgram through FY2026 | Terminated |
| J9213 | Injection, interferon, alfa-2a, recombinant, 3 million units | Valid |
| J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units | Valid |
| J9215 | Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu | Valid |
| J9216 | Injection, interferon, gamma 1-b, 3 million units | Valid |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Valid |
| J9218 | Leuprolide acetate, per 1 mg | Valid |
| J9219 | Leuprolide acetate implant, 65 mg | Valid |
| J9220 | Injection, indigotindisulfonate sodium, 1 mg | Valid |
| J9223 | Injection, lurbinectedin, 0.1 mg | Valid |
| J9225 | Histrelin implant (vantas), 50 mg | Valid |
| J9226 | Histrelin implant (supprelin la), 50 mg | Valid |
| J9227 | Injection, isatuximab-irfc, 10 mg | Valid |
| J9228 | Injection, ipilimumab, 1 mg | Valid |
| J9229 | Injection, inotuzumab ozogamicin, 0.1 mg | Valid |
| J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg | Valid |
| J9232 | Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg | Valid |
| J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg | Valid |
| J9246 | Injection, melphalan (evomela), 1 mg | Valid |
| J9247 | Injection, melphalan flufenamide, 1mg through FY2026 | Terminated |
| J9248 | Injection, melphalan (hepzato), 1 mg | Valid |
| J9249 | Injection, melphalan (apotex), 1 mg | Valid |
| J9250 | Methotrexate sodium, 5 mg through FY2026 | Terminated |
| J9255 | Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg | Valid |
| J9256 | Injection, nipocalimab-aahu, 3 mg | Valid |
| J9258 | Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg through FY2026 | Terminated |
| J9259 | Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg through FY2026 | Terminated |
| J9260 | Injection, methotrexate sodium, 50 mg | Valid |
| J9261 | Injection, nelarabine, 50 mg | Valid |
| J9262 | Injection, omacetaxine mepesuccinate, 0.01 mg | Valid |
| J9263 | Injection, oxaliplatin, 0.5 mg | Valid |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Valid |
| J9265 | Injection, paclitaxel, 30 mg through FY2026 | Terminated |
| J9266 | Injection, pegaspargase, per single dose vial | Valid |
| J9267 | Injection, paclitaxel, 1 mg | Valid |
| J9268 | Injection, pentostatin, 10 mg | Valid |
| J9269 | Injection, tagraxofusp-erzs, 10 micrograms | Valid |
| J9270 | Injection, plicamycin, 2.5 mg through FY2026 | Terminated |
| J9271 | Injection, pembrolizumab, 1 mg | Valid |
| J9272 | Injection, dostarlimab-gxly, 10 mg | Valid |
| J9273 | Injection, tisotumab vedotin-tftv, 1 mg | Valid |
| J9274 | Injection, tebentafusp-tebn, 1 microgram | Valid |
| J9275 | Injection, cosibelimab-ipdl, 2 mg | Valid |
| J9276 | Injection, zanidatamab-hrii, 2 mg | Valid |
| J9277 | Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph | Valid |
| J9278 | Injection, carboplatin (avyxa), 1 mg | Valid |
| J9280 | Injection, mitomycin, 5 mg | Valid |
| J9281 | Mitomycin pyelocalyceal instillation, 1 mg | Valid |
| J9282 | Mitomycin, intravesical instillation, 1 mg | Valid |
| J9285 | Injection, olaratumab, 10 mg | Valid |
| J9286 | Injection, glofitamab-gxbm, 2.5 mg | Valid |
| J9289 | Injection, nivolumab, 2 mg and hyaluronidase-nvhy | Valid |
| J9292 | Injection, pemetrexed dipotassium, 10 mg | Valid |
| J9293 | Injection, mitoxantrone hydrochloride, per 5 mg | Valid |
| J9294 | Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg | Valid |
| J9295 | Injection, necitumumab, 1 mg | Valid |
| J9296 | Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg | Valid |
| J9297 | Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg | Valid |
| J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg | Valid |
| J9299 | Injection, nivolumab, 1 mg | Valid |
| J9300 | Injection, gemtuzumab ozogamicin, 5 mg through FY2026 | Terminated |
| J9301 | Injection, obinutuzumab, 10 mg | Valid |
| J9302 | Injection, ofatumumab, 10 mg | Valid |
| J9303 | Injection, panitumumab, 10 mg | Valid |
| J9304 | Injection, pemetrexed (pemfexy), 10 mg | Valid |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | Valid |
| J9306 | Injection, pertuzumab, 1 mg | Valid |
| J9307 | Injection, pralatrexate, 1 mg | Valid |
| J9308 | Injection, ramucirumab, 5 mg | Valid |
| J9309 | Injection, polatuzumab vedotin-piiq, 1 mg | Valid |
| J9310 | Injection, rituximab, 100 mg through FY2026 | Terminated |
| J9311 | Injection, rituximab 10 mg and hyaluronidase | Valid |
| J9312 | Injection, rituximab, 10 mg | Valid |